Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy

The detection of rare mutational targets in plasma (liquid biopsy) has emerged as a promising tool for the assessment of patients with cancer. We determined the presence of cell-free DNA containing the BRAFV600E mutations (cfBRAFV600E) in plasma samples from 57 patients with papillary thyroid cancer...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med
Auteurs principaux: Jensen, Kirk, Thakur, Shilpa, Patel, Aneeta, Mendonca-Torres, Maria Cecilia, Costello, John, Gomes-Lima, Cristiane Jeyce, Walter, Mary, Wartofsky, Leonard, Burman, Kenneth Dale, Bikas, Athanasios, Ylli, Dorina, Vasko, Vasyl V., Klubo-Gwiezdzinska, Joanna
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7464493/
https://ncbi.nlm.nih.gov/pubmed/32748840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082481
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires